PATIENT ACTIVATION AND ADHERENCE TO BIOLOGICAL THERAPY AND TARGETED SYNTHETIC DMARD: PRELIMINARY RESULTS

Por: Sendra-Garcia, A, Llopis-Salvia, P, Hermenegildo-Caudevilla, M, Aguilar-Zamora, M, Montolio-Chiva, L, Vera, A, Vazquez-Gomez, I, Martinez-Ferrer, A, Ybanez-Garcia, D, Valls-Pascual, E, Nunez-Monje, V, Torner-Hernandez, I, Climente-Marti, M and Alegre-Sancho, J

---

Publicada: 1 jun 2019

---

---

Filiaciones:
:
 Univ Hosp Doctor Peset, Rheumatol & Pharm Dept, Valencia, Spain

 FISABIO, Valencia, Spain

:
 Dr Peset Univ Hosp, Dept Pharm, Valencia, Spain

:
 Dr Peset Univ Hosp, Dept Pharm, Valencia, Spain

:
 Dr Peset Univ Hosp, Rheumatol, Valencia, Spain

:
 Dr Peset Univ Hosp, Rheumatol, Valencia, Spain

:
 Dr Peset Univ Hosp, Rheumatol, Valencia, Spain

:
 Dr Peset Univ Hosp, Rheumatol, Valencia, Spain

:
 Dr Peset Univ Hosp, Rheumatol, Valencia, Spain

:
 Dr Peset Univ Hosp, Rheumatol, Valencia, Spain

:
 Dr Peset Univ Hosp, Rheumatol, Valencia, Spain

:
 Dr Peset Univ Hosp, Rheumatol, Valencia, Spain

:
 Dr Peset Univ Hosp, Rheumatol, Valencia, Spain

:
 Dr Peset Univ Hosp, Dept Pharm, Valencia, Spain

:
 Dr Peset Univ Hosp, Rheumatol, Valencia, Spain